Latest Articles

Publication Date
Activated CD8(+) tissue-resident memory T cells impact the endometrial receptivity in minimal/mild endometriosis.

Endometrial immune disorders create an inhospitable endometrial environment for embryonic nidation in endometriosis. CD8 + tissue resident memory T cells (CD8 +TRM) are abundant tissue resident immune cells in endometrium, …

Published: Oct. 8, 2025, midnight
Case Report: A patient with lynch syndrome with vaginal endometriosis-associated malignancy and synchronous colonic tubulovillous adenoma.

Endometriosis is a common gynecological condition. However, endometriosis-associated malignancies occur in up to 1% of women with endometriosis. Most cases of endometriosis-associated malignancy occur in the ovary, whereas 20% of …

Published: Oct. 8, 2025, midnight
Novel applications of gene and cell therapies in the treatment of gynecological disorders.

Gynecologic disorders, such as cervical and ovarian tumors, uterine fibroids, and endometriosis, present significant clinical challenges due to frequent recurrence, emerging chemoresistance, and undesirable effects associated with prolonged hormonal treatments. …

Published: Oct. 8, 2025, midnight
Exploring biopsychosocial health outcomes in endometriosis and endometriosis with co-occurring irritable bowel syndrome - A prospective cohort study.

To date there has been limited exploration of the impact of endometriosis with co-occurring irritable bowel syndrome (IBS) type symptoms on biopsychosocial health outcomes and wellbeing. This study aimed to …

Published: Oct. 8, 2025, midnight
All The Benefits of Menstrual Cycle Awareness - stellar.ie

All The Benefits of Menstrual Cycle Awareness stellar.ie

Published: Oct. 7, 2025, 9:14 p.m.
Study Identifies NNMT Deficiency in Endometrial Cells as a Contributor to Recurrent Implantation Failure - geneonline.com

Study Identifies NNMT Deficiency in Endometrial Cells as a Contributor to Recurrent Implantation Failure geneonline.com

Published: Oct. 7, 2025, 9:09 p.m.
Knight Therapeutics Announces Relaunch of MYFEMBREE® in Canada - GlobeNewswire

Knight Therapeutics Announces Relaunch of MYFEMBREE® in Canada GlobeNewswire

Published: Oct. 7, 2025, 9:08 p.m.
Insufficient NNMT Disrupts Implantation via H3K9me3 Pathway - BIOENGINEER.ORG

Insufficient NNMT Disrupts Implantation via H3K9me3 Pathway BIOENGINEER.ORG

Published: Oct. 7, 2025, 8:52 p.m.
Insufficient NNMT Disrupts Implantation via H3K9me3 Pathway - Bioengineer.org

Insufficient NNMT Disrupts Implantation via H3K9me3 Pathway Bioengineer.org

Published: Oct. 7, 2025, 8:52 p.m.
Championing a little-known IVF alternative - wng.org

Championing a little-known IVF alternative wng.org

Published: Oct. 7, 2025, 8:02 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!